Global Bariatric Surgery Devices Market Set To Grow To $1.5bn By 2023

The Global Bariatric Surgery Devices Market is estimated at $879.7m in 2017 and is expected to grow at a CAGR of 9.4% from 2018-2023. In 2017, the Global Bariatric Surgery Devices market was dominated by the Assisting Devices submarket which held 57% of the overall market.

LONDON, UK. February 2018: Visiongain has launched a new pharma report Global Bariatric Surgery Devices Market Forecast 2018-2028: Assisting Devices, Implantable Devices, Suturing Devices, Stapling Devices, Closure Devices, Trocars, Gastric Bands, Intragastric Balloons, Single Intragastric Balloons, Dual Intragastric Balloons, Triple Intragastric Balloons, Electrical Stimulation Devices, Gastric Emptying, Gastric Bypass, Sleeve Gastrectomy, Gastric Banding, Bariatric Surgery Clinics, Ambulatory Surgical Centres, Hospital Pharmacies

The bariatric surgery devices market is expected to witness a significant growth over the forecast period. The main drivers for the growth include rapid growth in the number of obese patients, growing incidences of obesity-related chronic disorders, and technological innovations in bariatric surgery systems. Additionally, government initiatives to curb obesity and related problems along with insurance coverage for bariatric procedures will further contribute to the growth of the market.

The lead analyst of the report commented “The demand for minimal invasive surgeries is growing rapidly as they save time, cost, and reduced hospital stay. In addition to this, governments are also encouraging the adoption of minimal invasive surgeries to lower the incidences of infection. Key players are striving to change the traditional methods of surgeries and developing innovative techniques to enable surgeons to perform bariatric surgeries more effectively.”

Leading companies featured in the report include Johnson & Johnson, Aspire Bariatrics, Inc.

GI Dynamics, Inc., Intuitive Surgical, Inc., Medtronic plc, Apollo Endosurgery, Inc., Mediflex, Cousin Biotech, Spatz FGIA Inc., The DACH Medical Group Holding AG (DACH), EnteroMedics Inc.

admin

Related posts